(Q28281756)
Statements
Delineation of the clinical, molecular and cellular aspects of novel JAM3 mutations underlying the autosomal recessive hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts (English)
0 references
March 2013
0 references
34
0 references
3
0 references
498-505
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference